Literature DB >> 7596336

Influenza and pneumococcal vaccination coverage levels among persons aged > or = 65 years--United States, 1973-1993.

.   

Abstract

Recommendations to provide annual influenza vaccination and one dose of pneumococcal vaccine to all persons aged > or = 65 years (1,2) are intended to reduce the high morbidity and mortality associated with influenza and pneumococcal disease. One of the national health objectives for the year 2000 is to increase influenza and pneumococcal vaccination levels to > or = 60% for persons at high risk for influenza and pneumococcal disease, including those aged > or = 65 years (objective 20.11) (3). This report summarizes 1) estimates of influenza vaccination coverage levels among persons aged > or = 65 years during 1973-1985 and pneumococcal vaccination coverage levels for 1984-1985 based on data from the United States Immunization Survey (USIS) and 2) influenza and pneumococcal vaccination coverage levels among persons aged > or = 65 years and for selected population subgroups during 1989-1993 based on data from the National Health Interview Survey (NHIS).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596336

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  11 in total

1.  Racial/ethnic differences in influenza vaccination coverage in high-risk adults.

Authors:  Leonard E Egede; Deyi Zheng
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

Review 2.  Increasing immunization rates among African-American adults.

Authors: 
Journal:  J Natl Med Assoc       Date:  2003-04       Impact factor: 1.798

3.  How good is the quality of health care in the United States? 1998.

Authors:  Mark A Schuster; Elizabeth A McGlynn; Robert H Brook
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

4.  Highlights of historical events leading to national surveillance of vaccination coverage in the United States.

Authors:  Philip J Smith; David Wood; Paul M Darden
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

Review 5.  The cost effectiveness of pneumococcal vaccination strategies.

Authors:  C B Gable; M Botteman; G Savage; K Joy
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

6.  Improving pneumococcal vaccine rates. Nurse protocols versus clinical reminders.

Authors:  D C Rhew; P A Glassman; M B Goetz
Journal:  J Gen Intern Med       Date:  1999-06       Impact factor: 5.128

7.  Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia.

Authors:  Gregory W Ruhnke; Marcelo Coca-Perraillon; Barrett T Kitch; David M Cutler
Journal:  Am J Med       Date:  2011-02       Impact factor: 4.965

8.  Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults.

Authors:  K L Nichol; R Mac Donald; M Hauge
Journal:  J Gen Intern Med       Date:  1996-11       Impact factor: 5.128

Review 9.  Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Authors:  Jördis J Ott; Janna Klein Breteler; John S Tam; Raymond C W Hutubessy; Mark Jit; Michiel R de Boer
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

Review 10.  Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.

Authors:  Daniel T Lackland; Edward J Roccella; Anne F Deutsch; Myriam Fornage; Mary G George; George Howard; Brett M Kissela; Steven J Kittner; Judith H Lichtman; Lynda D Lisabeth; Lee H Schwamm; Eric E Smith; Amytis Towfighi
Journal:  Stroke       Date:  2013-12-05       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.